ORCHARD THERAPEUTICS PLC Interest Expense
ORCHARD THERAPEUTICS PLC reported Interest Expense of $932.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2023-11-13
- ORCHARD THERAPEUTICS PLC interest expense for the quarter ending 2023-09-30 was $932.00K, a 16.65% increase year-over-year.
- ORCHARD THERAPEUTICS PLC interest expense for the quarter ending 2023-06-30 was $975.00K, a 45.09% increase year-over-year.
- ORCHARD THERAPEUTICS PLC interest expense for the quarter ending 2023-03-31 was $957.00K, a 41.78% increase year-over-year.
- ORCHARD THERAPEUTICS PLC interest expense for the quarter ending 2022-12-31 was $933.00K, a 36.60% increase year-over-year.
- ORCHARD THERAPEUTICS PLC interest expense for fiscal 2022 was $3.08M, a 23.31% increase from fiscal 2021.
- ORCHARD THERAPEUTICS PLC interest expense for fiscal 2021 was $2.50M, a 7.26% increase from fiscal 2020.
- ORCHARD THERAPEUTICS PLC interest expense for fiscal 2020 was $2.33M, a 51.37% increase from fiscal 2019.
- ORCHARD THERAPEUTICS PLC interest expense for fiscal 2019 was $1.54M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $932.00K 10-Q · filed 2023-11-13 | $1.91M derived: sum of 2 quarters · filed 2023-11-13 | $2.86M 10-Q · filed 2023-11-13 | $3.80M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $975.00K 10-Q · filed 2023-08-10 | $1.93M 10-Q · filed 2023-08-10 | $2.87M derived: sum of 3 quarters · filed 2023-08-10 | $3.66M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | $957.00K 10-Q · filed 2023-05-15 | $1.89M derived: sum of 2 quarters · filed 2023-05-15 | $2.69M derived: sum of 3 quarters · filed 2023-11-13 | $3.36M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $933.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.73M derived: sum of 2 quarters · filed 2023-11-13 | $2.40M derived: sum of 3 quarters · filed 2023-11-13 | $3.08M 10-K · filed 2023-03-14 |
| 2022-09-30 | $799.00K 10-Q · filed 2023-11-13 | $1.47M derived: sum of 2 quarters · filed 2023-11-13 | $2.15M 10-Q · filed 2023-11-13 | $2.83M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $672.00K 10-Q · filed 2023-08-10 | $1.35M 10-Q · filed 2023-08-10 | $2.03M derived: sum of 3 quarters · filed 2023-08-10 | $2.71M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $675.00K 10-Q · filed 2023-05-15 | $1.36M derived: sum of 2 quarters · filed 2023-05-15 | $2.04M derived: sum of 3 quarters · filed 2023-05-15 | $2.63M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $683.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.37M derived: sum of 2 quarters · filed 2023-03-14 | $1.96M derived: sum of 3 quarters · filed 2023-03-14 | $2.50M 10-K · filed 2023-03-14 |
| 2021-09-30 | $683.00K 10-Q · filed 2022-11-14 | $1.28M derived: sum of 2 quarters · filed 2022-11-14 | $1.81M 10-Q · filed 2022-11-14 | $2.39M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $593.00K 10-Q · filed 2022-08-04 | $1.13M 10-Q · filed 2022-08-04 | $1.71M derived: sum of 3 quarters · filed 2022-08-04 | $2.28M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $538.00K 10-Q · filed 2022-05-12 | $1.11M derived: sum of 2 quarters · filed 2022-05-12 | $1.69M derived: sum of 3 quarters · filed 2022-05-12 | $2.25M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $575.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.15M derived: sum of 2 quarters · filed 2022-03-30 | $1.72M derived: sum of 3 quarters · filed 2022-03-30 | $2.33M 10-K · filed 2022-03-30 |
| 2020-09-30 | $572.00K 10-Q · filed 2021-11-04 | $1.14M derived: sum of 2 quarters · filed 2021-11-04 | $1.75M 10-Q · filed 2021-11-04 | $2.39M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $568.00K 10-Q · filed 2021-08-04 | $1.18M 10-Q · filed 2021-08-04 | $1.81M derived: sum of 3 quarters · filed 2021-08-04 | $2.47M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $613.00K 10-Q · filed 2021-05-13 | $1.25M derived: sum of 2 quarters · filed 2021-05-13 | $1.91M derived: sum of 3 quarters · filed 2021-05-13 | $2.15M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $633.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $1.29M derived: sum of 2 quarters · filed 2021-03-02 | $1.54M derived: sum of 3 quarters · filed 2021-03-02 | $1.54M 10-K · filed 2021-03-02 |
| 2019-09-30 | $660.00K 10-Q · filed 2020-11-03 | $905.00K derived: sum of 2 quarters · filed 2020-11-03 | $905.00K 10-Q · filed 2020-11-03 | |
| 2019-06-30 | $245.00K 10-Q · filed 2020-08-06 | $245.00K 10-Q · filed 2020-08-06 |